Rani Therapeutics Holdings, a clinical-stage biotherapeutics company based in San Jose, California, focuses on developing oral delivery technologies like the RaniPill capsule for biologics and drugs. The company went public on July 30, 2021, and has a pipeline that includes multiple drug candidates.
Rani Therapeutics Holdings (RANI) reported a positive EPS surprise in its most recent quarterly earnings. For the most recent quarter, Rani Therapeutics Holdings's actual EPS was -$0.24, beating the estimate of -$0.26 per share, resulting in a 8.92% surprise.
📡️ Health Care
Earnings Surprise
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
